These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34782275)

  • 21. Methods for Experimental Allergen Immunotherapy: Subcutaneous and Sublingual Desensitization in Mouse Models of Allergic Asthma.
    Hesse L; Petersen AH; Nawijn MC
    Methods Mol Biol; 2021; 2223():295-335. PubMed ID: 33226602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation.
    Suárez-Fueyo A; Ramos T; Galán A; Jimeno L; Wurtzen PA; Marin A; de Frutos C; Blanco C; Carrera AC; Barber D; Varona R
    J Allergy Clin Immunol; 2014 Jan; 133(1):130-8.e1-2. PubMed ID: 24290282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune mechanisms of allergen-specific sublingual immunotherapy.
    Moingeon P; Batard T; Fadel R; Frati F; Sieber J; Van Overtvelt L
    Allergy; 2006 Feb; 61(2):151-65. PubMed ID: 16409190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variation in allergen content in sublingual allergen immunotherapy with house dust mites.
    Moreno Benítez F; Espinazo Romeu M; Letrán Camacho A; Mas S; García-Cózar FJ; Tabar AI
    Allergy; 2015 Nov; 70(11):1413-20. PubMed ID: 26185961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered chromatin landscape in circulating T follicular helper and regulatory cells following grass pollen subcutaneous and sublingual immunotherapy.
    Sharif H; Acharya S; Dhondalay GKR; Varricchi G; Krasner-Macleod S; Laisuan W; Switzer A; Lenormand M; Kashe E; Parkin RV; Yi Y; Koc M; Fedina O; Vilà-Nadal G; Marone G; Eifan A; Scadding GW; Fear DJ; Nadeau KC; Durham SR; Shamji MH
    J Allergy Clin Immunol; 2021 Feb; 147(2):663-676. PubMed ID: 33160969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Importance of Tablet Formulation on Allergen Release Kinetics and Efficiency: Comparison of Freeze-dried and Compressed Grass Pollen Sublingual Allergy Immunotherapy Tablet Formulations.
    Lund K; Kito H; Skydtsgaard MB; Nakazawa H; Ohashi-Doi K; Lawton S
    Clin Ther; 2019 Apr; 41(4):742-753. PubMed ID: 30885398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation.
    Bohle B; Kinaciyan T; Gerstmayr M; Radakovics A; Jahn-Schmid B; Ebner C
    J Allergy Clin Immunol; 2007 Sep; 120(3):707-13. PubMed ID: 17681368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bet v 1 contiguous overlapping peptides anchored to virosomes with TLR4 agonist enhance immunotherapy efficacy in mice.
    Airouche S; Beltrami V; Fleury S; Batard T; Bordas-Le Floch V; Stegmann T; Amacker M; Kettner A; Mascarell L
    Clin Exp Allergy; 2021 Feb; 51(2):339-349. PubMed ID: 33368719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T cell targeted strategies for improved efficacy and safety of specific immunotherapy for allergic disease.
    Rolland JM; Prickett S; Gardner LM; O'Hehir RE
    Antiinflamm Antiallergy Agents Med Chem; 2013; 12(3):201-22. PubMed ID: 23597085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of Subcutaneous and Sublingual Aeroallergen Immunotherapy: What Is New?
    Komlósi ZI; Kovács N; Sokolowska M; van de Veen W; Akdis M; Akdis CA
    Immunol Allergy Clin North Am; 2020 Feb; 40(1):1-14. PubMed ID: 31761112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sublingual immunotherapy mechanisms of action: the role of Th1 response.
    Ciprandi G; Tosca MA; Marseglia GL
    Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):9-12. PubMed ID: 19944003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CpG Adjuvant in Allergen-Specific Immunotherapy: Finding the Sweet Spot for the Induction of Immune Tolerance.
    Montamat G; Leonard C; Poli A; Klimek L; Ollert M
    Front Immunol; 2021; 12():590054. PubMed ID: 33708195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extraction, Purification, and Development of Sublingual Film (SLIT Films) Comprising Cockroach Allergen for Treatment of Allergy.
    Anita L; D P V; B SK; Kanni P; Ramnarayanan C; Karki R; Komarla NP; Janadri S
    Curr Drug Deliv; 2023; 20(6):807-817. PubMed ID: 35718958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct modulation of allergic T cell responses by subcutaneous vs. sublingual allergen-specific immunotherapy.
    Schulten V; Tripple V; Aasbjerg K; Backer V; Lund G; Würtzen PA; Sette A; Peters B
    Clin Exp Allergy; 2016 Mar; 46(3):439-48. PubMed ID: 26436865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel mechanisms in immune tolerance to allergens during natural allergen exposure and allergen-specific immunotherapy.
    van de Veen W; Wirz OF; Globinska A; Akdis M
    Curr Opin Immunol; 2017 Oct; 48():74-81. PubMed ID: 28888176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T-cell responses during allergen-specific immunotherapy.
    Maggi E; Vultaggio A; Matucci A
    Curr Opin Allergy Clin Immunol; 2012 Feb; 12(1):1-6. PubMed ID: 22157159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in improving intranasal allergen-specific immunotherapy; focus on delivery systems and adjuvants.
    Sadeghi M; Asadirad A; Koushki K; Keshavarz Shahbaz S; Dehnavi S
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109327. PubMed ID: 36257257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-course sublingual immunotherapy by mucoadhesive patch and tolerogenic particle enhanced allergen presentation.
    Sørensen P; Turánek-Knotigová P; Mašek J; Kotouček J; Hubatka F; Mašková E; Kulich P; Lubasová D; Raška M; Leenhouts K; Turánek J
    Clin Exp Allergy; 2021 Jun; 51(6):853-857. PubMed ID: 33682209
    [No Abstract]   [Full Text] [Related]  

  • 39. Bioavailability of House Dust Mite Allergens in Sublingual Allergy Tablets Is Highly Dependent on the Formulation.
    Ohashi-Doi K; Kito H; Du W; Nakazawa H; Ipsen H; Gudmann P; Lund K
    Int Arch Allergy Immunol; 2017; 174(1):26-34. PubMed ID: 28950271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sublingual Immunotherapy for the Polyallergic Patient.
    Pepper AN; Calderón MA; Casale TB
    J Allergy Clin Immunol Pract; 2017; 5(1):41-45. PubMed ID: 27452888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.